Janus Kinase (jak) Inhibitor - Cancer Science

Relevant Publications

[Application of advanced treatment in chronic inflammatory bowel diseases].

Issue Release: 2025

Momelotinib for the treatment of myelofibrosis.

Issue Release: 2024

Threonine Deficiency Increases Triglyceride Deposition in Primary Duck Hepatocytes by Reducing STAT3 Phosphorylation.

Issue Release: 2024

Ruxolitinib as a CaMKII Inhibitor for the Treatment of Cardiac Arrhythmias: Applications and Prospects.

Issue Release: 2024

Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study.

Issue Release: 2024

Evaluation of ruxolitinib cream 1.5% as an at-home therapy for repigmentation in non-segmental vitiligo.

Issue Release: 2024

Efficacy and Safety of Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction for Intractable Ulcerative Colitis.

Issue Release: 2024

Real-world experience with filgotinib for rheumatoid arthritis in Germany : A retrospective chart review.

Issue Release: 2024

Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies.

Issue Release: 2024

Real-world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients.

Issue Release: 2024

Plant-based zinc nanoflowers assisted molecularly imprinted polymer for the design of an electrochemical sensor for selective determination of abrocitinib.

Issue Release: 2024

Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial.

Issue Release: 2024

Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata.

Issue Release: 2024

Disease modification in axial spondyloarthritis - still a controversy?

Issue Release: 2024

Thymic Stromal Lymphopoietin Activates Mouse Dendritic Cells Through the JAK/SYK Pathway in Promoting Th17 Response in Psoriasis.

Issue Release: 2024

Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies.

Issue Release: 2024

JAK/STAT Inhibition Normalizes Lipid Composition in 3D Human Epidermal Equivalents Challenged with Th2 Cytokines.

Issue Release: 2024

Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database.

Issue Release: 2024

Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib.

Issue Release: 2024

Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches.

Issue Release: 2024

What Role Does Telemedicine Play in Cancer Treatment?

How Can Patients Ensure Comprehensive Cancer Care in an EPO?

What Are the Common Indoor Air Pollutants?

What Are Some Challenges in Using Proteomic Markers?

What is the Role of Kinases in Cancer?

What is the significance of early detection and screening in cancer demographics?

How Do Therapeutic Interventions Target Feedback Mechanisms?

What Are the Latest Advances in Cancer Screening?

How Does the Microenvironment Influence Tumor Growth?

How does the variability in biomarkers affect cancer interpretation?

Partnered Content Networks

Relevant Topics